☰

Yongzhen Li - Publications

Affiliations: 
Qinghai University 
Area:
microbial metabolites, natural products
Tree Info Grants Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Xu Y, Liu C, Han X, Jia X, Li Y, Liu C, Li N, Liu L, Liu P, Jiang X, Wang W, Wang X, Li Y, Chen M, Luo J, et al. E17241 as a Novel ABCA1 (ATP-Binding Cassette Transporter A1) Upregulator Ameliorates Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314156. PMID 33441025 DOI: 10.1161/ATVBAHA.120.314156  0.587
2020 Luo J, Wang X, Jiang X, Liu C, Li Y, Han X, Zuo X, Li Y, Li N, Xu Y, Si S. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 34: 1398-1411. PMID 31914630 DOI: 10.1096/Fj.201900903Rrr  0.599
2019 Jia XJ, Du Y, Jiang HJ, Li YZ, Xu YN, Si SY, Wang L, Hong B. Identification of Novel Compounds Enhancing SR-BI mRNA Stability through High-Throughput Screening. Slas Discovery : Advancing Life Sciences R & D. 2472555219894543. PMID 31858876 DOI: 10.1177/2472555219894543  0.6
2018 Feng T, Liu P, Wang X, Luo J, Zuo X, Jiang X, Liu C, Li Y, Li N, Chen M, Zhu N, Han X, Liu C, Xu Y, Si S. SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Atherosclerosis. 274: 172-181. PMID 29787963 DOI: 10.1016/J.Atherosclerosis.2018.04.039  0.605
2017 Si S, Feng T, Liu P, Wang X, Liu C, Li N, Zhu N, Chen M, Li Y, Han X, Liu C, Xu Y. E1231, an activator of SIRT1, regulates cholesterol and lipid metabolism through SIRT1-LXRALPHA-ABCA1 pathway. Atherosclerosis. 263: e75. PMID 29366216 DOI: 10.1016/J.Atherosclerosis.2017.06.248  0.578
2015 Liu C, Feng T, Zhu N, Liu P, Han X, Chen M, Wang X, Li N, Li Y, Xu Y, Si S. Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Scientific Reports. 5: 12185. PMID 26244753 DOI: 10.1038/srep12185  0.512
2015 Liu C, Feng T, Zhu N, Liu P, Han X, Chen M, Wang X, Li N, Li Y, Xu Y, Si S. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Scientific Reports. 5: 9530. PMID 25827822 DOI: 10.1038/Srep09530  0.583
2015 Chen M, Wu Y, He Y, Xu Y, Li Y, Li D, Feng T, Yu L, Hong B, Jiang W, Si S. Identification of trichostatin derivatives from Streptomyces sp. CPCC 203909. Bioorganic & Medicinal Chemistry Letters. 25: 562-5. PMID 25556102 DOI: 10.1016/J.Bmcl.2014.12.030  0.575
2014 Li N, Wang X, Zhang J, Liu C, Li Y, Feng T, Xu Y, Si S. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening. Biochemical Pharmacology. 92: 438-47. PMID 25450668 DOI: 10.1016/J.Bcp.2014.09.017  0.654
2014 Feng TT, Li YZ, Li N, Liu C, Wang X, Xu YN, Si SY. [The in vitro anti-atherosclerotic activity of compound IMB-1680]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 49: 602-7. PMID 25151728  0.576
2014 Li Y, Feng T, Liu P, Liu C, Wang X, Li D, Li N, Chen M, Xu Y, Si S. Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis. Acs Medicinal Chemistry Letters. 5: 884-8. PMID 25147608 DOI: 10.1021/Ml500131A  0.605
2014 Xu Y, Liu Q, Xu Y, Liu C, Wang X, He X, Zhu N, Liu J, Wu Y, Li Y, Li N, Feng T, Lai F, Zhang M, Hong B, et al. Rutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT. Journal of Lipid Research. 55: 1634-1647. PMID 24908654 DOI: 10.1194/jlr.M044198  0.59
2014 Li Y, Zhang X, Zhang J, Li Y, Liu W, Wang Z, Wang Y, Si S. A small molecule, MTBT, prevents cancer cell growth by activating p38 MAPK. Anti-Cancer Drugs. 25: 423-32. PMID 24441745 DOI: 10.1097/Cad.0000000000000074  0.556
2014 Li N, Xu Y, Feng T, Liu C, Li Y, Wang X, Si S. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library. Journal of Biomolecular Screening. 19: 566-74. PMID 24334278 DOI: 10.1177/1087057113516004  0.639
2012 Liu X, Gan M, Dong B, Zhang T, Li Y, Zhang Y, Fan X, Wu Y, Bai S, Chen M, Yu L, Tao P, Jiang W, Si S. 4862F, a new inhibitor of HIV-1 protease, from the culture of Streptomyces I03A-04862. Molecules (Basel, Switzerland). 18: 236-43. PMID 23271463 DOI: 10.3390/Molecules18010236  0.485
2012 Han X, Zhang J, Guo L, Cao R, Li Y, Li N, Ma Q, Wu J, Wang Y, Si S. A series of beta-carboline derivatives inhibit the kinase activity of PLKs. Plos One. 7: e46546. PMID 23056340 DOI: 10.1371/Journal.Pone.0046546  0.583
2012 Lin Y, Li Y, Zhu Y, Zhang J, Li Y, Liu X, Jiang W, Yu S, You XF, Xiao C, Hong B, Wang Y, Jiang JD, Si S. Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system. Proceedings of the National Academy of Sciences of the United States of America. 109: 17412-7. PMID 23045703 DOI: 10.1073/Pnas.1110271109  0.532
Show low-probability matches.